Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

Dr Yoshinori Yamano

Nemesis bioscience announces the appointment of Dr Yoshinori Yamano as non-executive director

15th July 2022

Nemesis Bioscience Ltd announced today that it had appointed Dr Yoshinori Yamano to its board as a non-executive director.
Andy Muir, Alexander Leigh

Science Ventures Series: Valuation of start-ups as a seed investor

12th July 2022

We base our business model on the “power law” and estimate two out of ten early-stage investments will generate extraordinary financial return to cover the entire value of the fund.
test tubes

CHAIN Biotech and the University of Oxford collaborate to tackle oral vaccine inequality

15th June 2022

CHAIN announces a new collaboration with clinical researchers at the University of Oxford to develop superior oral vaccines for infectious diseases.
Richard Anderson

Science Venture Series: How can start-ups build a strong reputation?

7th June 2022

What is your most crucial piece of advice to founders and entrepreneurs building a reputation for their businesses?
Make brand building a core part of your strategy…
Damien Weidmann

CSO Spotlight: Damien Weidmann, CSO of Mirico

31st May 2022

The main market that we are addressing relates to greenhouse gases because of the need to measure and monitor them to control emissions.
biomaterials

Zentraxa announce seed financing to progress their platform technology for precision biomaterials

27th May 2022

Zentraxa are excited to announce capital investment from Future Planet Capital, Bristol Private Equity Club (BPEC) and Science Angel Syndicate to develop their innovative Zentide…
Guy Levy-Yurista

Science Ventures Series: UK start-ups & later-stage fundraising

5th May 2022

What is the most important aspect in later stage funding? Demonstrating product-market fit and associated exponential commercial growth…
Steve bennington

CEO Spotlight: Steve Bennington, CEO of Q5D

26th April 2022

Steve Bennington, CEO of Q5D, speaks to UKI2S about his journey in science ventures and engineering.
bioprocessing technology

MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases

25th April 2022

MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases…
Tokamak Energy

From £25,000 to 100M degrees

10th March 2022

In 2010, UKI2S made a £25,000 pathfinder investment in Tokamak Energy, a spin-out from the Culham Centre for Fusion Energy, to support the commercial development of a fusion neutron device.

Marie McAvoy

NanoSyrinx appoints R&D industry leader Dr Marie McAvoy as Chief Scientific Officer

10th March 2022

Sciad Newswire / NanoSyrinx, a biotech company using engineering biology approaches to develop a new modality for the targeted intracellular delivery of biologic therapeutics…
Lab work

HydRegen receives funding to implement their proprietary enzyme platform into sustainable chemical processes

1st March 2022

HydRegen, the revolutionary bioscience company, enables sustainable chemical manufacturing using their proprietary enzyme based redox platform.
Cows

Mirico monitors impact of cattle grazing and fertiliser strategies on agricultural greenhouse gas emissions

1st March 2022

Mirico is collaborating with partners in the agricultural sector to baseline and understand greenhouse gas emissions associated with cattle farms, helping with sector plans to reach net zero.
manufacture

Q5D Technology announces a $2.5m seed investment to take its technology and business to the next stage

2nd February 2022

Q5D Technology is excited to announce a $2.5m seed investment in order to take its technology and business to the next stage.
OSS banner

Oxford Space Systems in ground-breaking programme for Innovative Space Solutions

1st February 2022

Oxford Space Systems (OSS) has announced an investment round, subject to final completion, of approximately £4 million to accelerate development of its existing deployable antenna…
Medication

CellCentric secures investment from the American Cancer Society’s impact venture capital fund

26th January 2022

Inobrodib is the first drug to target p300/CBP, a new way to treat specific cancers.  Following a successful Phase I campaign, new funding will be used to…
Gherkin

Review of 2021

21st January 2022

A year of global challenges emphasises the role of science and technology in our changing world.
Viewing screen

Helix Geospace raises £3m Seed funding to take its world-leading GPS antennas into mass production

17th December 2021

Helix Geospace, the leading innovator in antenna and RF (radio frequency) technology, is pleased to announce that it has raised £3million seed funding in a round led by Bloc Ventures.
Keith Thompson

An Interview with Keith Thompson – Chair of NK:IO

16th December 2021

Keith Thompson is the current chair of biotech start-up NK:IO. He’s also chair of the Pharma Advisory Board of Deep Science Ventures and acted as industry advisor to the Vaccines Taskforce.
surveying

Mirico joins industry consortium to guide European methane emissions regulation

8th December 2021

With the Global Methane Pledge launched at COP26 and new regulation being developed to cover Europe, Mirico’s methane emissions monitoring solution was showcased as…
Atheras Analytics Satelite

Atheras Analytics receives funding from UKI2S to launch its SaaS platform to improve satellite link availability

11th November 2021

Atheras Analytics, a UK-based company in the satellite telecommunications sector, has secured funding from the UK Innovation & Science Seed Fund (UKI2S).

Gilad Gershon

CEO Spotlight: Gilad Gershon, CEO of Tropic Biosciences

8th November 2021

Founded by Gilad Gershon and Dr Eyal Maori, Tropic Biosciences uses cutting-edge technologies to develop tropical crop varieties with enhanced nutritional benefits…
Andrew Mackintosh

How investing public money can support the development of technologies for a greener future

25th October 2021

In the lead up to COP26, Andrew Mackintosh, the newly appointed Chair of UK Innovation and Science Seed Fund (UKI2S) Advisory Board…
Ann Kramer

CEO Spotlight: Ann Kramer, CEO The Electrospinning Company

15th October 2021

The Electrospinning Company (ESC) was established in 2010 as a spin-out by the UK Science and Technology Facilities Council (STFC). ESC is located in purpose-built…
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.